Bremelanotide acetate - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for bremelanotide acetate and what is the scope of freedom to operate?
Bremelanotide acetate
is the generic ingredient in one branded drug marketed by Palatin Technologies and is included in one NDA. There are five patents protecting this compound. Additional information is available in the individual branded drug profile pages.Bremelanotide acetate has eighty patent family members in twenty-six countries.
One supplier is listed for this compound.
Summary for bremelanotide acetate
International Patents: | 80 |
US Patents: | 5 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Clinical Trials: | 1 |
DailyMed Link: | bremelanotide acetate at DailyMed |
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for bremelanotide acetate
Generic Entry Date for bremelanotide acetate*:
Constraining patent/regulatory exclusivity:
NEW CHEMICAL ENTITY Dosage:
SOLUTION;SUBCUTANEOUS |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Recent Clinical Trials for bremelanotide acetate
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Palatin Technologies, Inc | Phase 2 |
Pharmacology for bremelanotide acetate
Drug Class | Melanocortin Receptor Agonist |
Mechanism of Action | Melanocortin Receptor Agonists |
US Patents and Regulatory Information for bremelanotide acetate
Expired US Patents for bremelanotide acetate
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Palatin Technologies | VYLEESI (AUTOINJECTOR) | bremelanotide acetate | SOLUTION;SUBCUTANEOUS | 210557-001 | Jun 21, 2019 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for bremelanotide acetate
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Ukraine | 118656 | ЗАСТОСУВАННЯ БРЕМЕЛАНОТИДУ У ЛІКУВАННІ ЖІНОЧОЇ СЕКСУАЛЬНОЇ ДИСФУНКЦІЇ (BREMELANOTIDE THERAPY FOR FEMALE SEXUAL DYSFUNCTION) | ⤷ Try a Trial |
Brazil | 112015009936 | método para tratar disfunção sexual feminina em uma paciente do sexo feminino diagnosticada com disfunção sexual feminina, mas desejando ter atividade sexual; uso de uma dose de formulação; bremelanotide para uso em um método para tratar disfunção sexual feminina; e unidade de dose pré-carregada | ⤷ Try a Trial |
Mexico | PA02000111 | COMPOSICIONES Y METODOS PARA EL TRATAMIENTO DE DISFUNCION SEXUAL. (COMPOSITIONS AND METHODS FOR TREATMENT OF SEXUAL DYSFUNCTION.) | ⤷ Try a Trial |
Mexico | 2007000311 | PEPTIDOS CICLICOS PARA EL TRATAMIENTO DE LA CAQUEXIA. (CYCLIC PEPTIDES FOR TREATMENT OF CACHEXIA.) | ⤷ Try a Trial |
European Patent Office | 1667700 | ⤷ Try a Trial | |
Mexico | 2015005486 | USOS DE BREMELANOTIDA EN TERAPIA PARA LA DISFUNCION SEXUAL FEMENINA. (BREMELANOTIDE THERAPY FOR FEMALE SEXUAL DYSFUNCTION.) | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.